Transactions
Showing 1657-1665 of 4595 items
-
US$690m
Ascendis Pharma
Co-Lead Manager (Follow-On)
-
US$517m
CRISPR
Co-Manager (Follow-On)
-
N/a
Cansortium
Financial Advisor (restructuring and consent consolidation)
-
£20m
Velocys
Joint Bookrunner and Joint Broker
-
N/a
IKO
Exclusive Financial Advisor on follow-on investment in SIG plc's equity raise
-
Dye & Durham
Financial Advisor on acquisition of Stanley Davis
-
Level Ex
Financial Advisor (Sell side)
-
US$48m
TELA Bio
Lead Manager (Follow-On)
-
US$29m
KORU Medical Systems
Joint Bookrunner (Follow-on Offering)